Antiserum to somatostatin reverses starvation-induced inhibition of growth hormone but not insulin secretion

Endocrinology. 1978 Jun;102(6):1909-14. doi: 10.1210/endo-102-6-1909.

Abstract

The role of SRIF in starvation-induced inhibition of GH and insulin secretion was assessed by passive immunization with anti-SRIF serum. Six-hour secretory profiles obtained from chronically cannulated male rats deprived of food for 72 h showed marked suppression of GH secretory bursts and significant depression of plasma insulin levels. Administration of 1 ml SRIF antiserum (SRIF AS) iv to starved rats resulted in rapid (within 15 min) restoration of high amplitude GH pulses (600-800 ng/ml) and sighificant elevation of GH trough values. The mean 6-h GH level of starved SRIF, AS-treated rats (189.2 +/- 23.9 ng/ml) was significantly higher than that of starved, normal sheep serum-treated control animals (62.8 +/- 5.8 ng/ml) (P less than 0.005). In contrast to the effects on GH, plasma insulin levels in starved rats administered SRIF AS remained low. No significant difference was observed in the mean 6-h plasma insulin level of starved-SRIF, AS-treated rats when compared to starved, normal sheep serum-treated controls. These findings suggest that circulating SRIF is a physiological regulator of starvation-induced GH suppression but is not involved in mediating the inhibition of insulin.

MeSH terms

  • Animals
  • Antibodies
  • Growth Hormone / blood
  • Growth Hormone / metabolism*
  • Immune Sera
  • Insulin / blood
  • Insulin / metabolism*
  • Insulin Secretion
  • Male
  • Rats
  • Somatostatin / immunology
  • Somatostatin / physiology*
  • Starvation / physiopathology*

Substances

  • Antibodies
  • Immune Sera
  • Insulin
  • Somatostatin
  • Growth Hormone